Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19
Abstract Recent studies on the pathophysiology of COVID-19 are indicating that the Angiotensin convertase enzyme 2 (ACE-2) and transmembrane serine protease 2 (TMPRSS2) can act as a major component in the fusion of SARS-Cov-2 with target cells. It has also been observed that the expression of ACE-2...
Main Authors: | Sepehr Shafiee, Luca Cegolon, Mostafa Khafaei, Nasrin Gholami, Shi Zhao, Nasrin Khalesi, Hamidreza Moosavian, Saeid Fathi, Morteza Izadi, Alireza Ghadian, Mohammad Javanbakht, Amin Javanbakht, Reza Akhavan-Sigari |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-08-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-021-02129-x |
Similar Items
-
RECURRENT OF TMPRSS2 GENETIC POLYMORPHISM AND ITS ROLE IN IRAQI PATIENTS WITH PROSTATE CANCER
by: Ammar K. A., et al.
Published: (2022-04-01) -
Variations in levels of ACE2 and TMPRSS2 receptors among COVID-19
by: Dalia Zanaty, et al.
Published: (2024-02-01) -
COVID-19 pandemic; transmembrane protease serine 2 (TMPRSS2) inhibitors as potential drugs.
by: Jerzy Jankun
Published: (2020-04-01) -
Smoke and Spike: Benzo[a]pyrene Enhances SARS‐CoV‐2 Infection by Boosting NR4A2‐Induced ACE2 and TMPRSS2 Expression
by: Wenbin Liu, et al.
Published: (2023-09-01) -
TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein
by: Mai Kishimoto, et al.
Published: (2021-02-01)